1Kameyama N, Arisawa S, Ueyama J, et al. Increase in P-glycoprotein accompanied by activation of protein kinase calpha and NF-kap- pa B p65 in the livers of rats with streptozotocin-induced diabetes [ J ]. Biochim Biophys Acta, 2008,1782 ( 5 ) : 355-360.
2Beaulieu E, Demeule M, Ghitescu L, et al. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain[J]. Biochem JH, 1997,326(2) :539-554.
3Kwan P, Sills GJ, Butler E, et al. Differential expression of multidrug resistance genes in naive rat brain [ J ]. Neurosci Lett, 2003, 339(1 ) :33-36.
4Dan Y, Murakami H, Koyabu N, et al. Distrubution of dompefidone into the rat brain is increased by vrain ischaemia or treatmentwith the P-glycoprotein inhibitor verapamil[ J]. J Pharm Pharmacol, 2002,54(5) :729-733.
5Akria T, Telsuya Y. P-glycoprotein as the drug efllux pump in primary cultured bovine capillary endothelial ceils [ J]. Life sciences, 1992,51 (18) : 1427.
6Bart J, WiUemsen AT, Groen H J, et al. Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of verapamil measured with PET[ J]. Neuroimage, 2003,20 (3) :1775-1782.
7Wang Q, Stran R, Kardos P, et al. Application and limitation of inhibitors in drug-transporter interactions studies [ J ]. Int J Pharm, 2008,356(1-2) :12-18.
8Cistemino S, Rousselle C, DagenJs C, et al. Screening of multidrug-resistance sensitive drugs by in situ brain pergusion in P-glyco- protein-degiclency mice[J]. Harm Res, 2001,18(2) :183-190.
9Barakat S, Turcotte S, Demeule M, et al. Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction [ J ]. Biochem Biophys Res Commun, 2008,372 ( 3 ) : 440-446.
7Akisa M, Kulttirsay N, Coker I, et al. Plasma platelet-activating factor levels in newborn infants with and without perinatal as- phyxia:is it an additional marker of perinatal asphyxia[J]. Acta Paediatr Jpn, 1998,40(5) : 427-431.
